Related Experiment Videos
[Therapeutic strategy for severe and fulminating ulcerative colitis]
Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 26, 1999
Summary
Accurate disease severity assessment is crucial for managing severe ulcerative colitis (UC). New treatments like cyclosporine and leucocytapheresis offer promising options, though surgical intervention timing remains debated.
Area of Science:
- Gastroenterology and Internal Medicine
Context:
- Severe and fulminating ulcerative colitis (UC) presents significant management challenges.
- Accurate disease severity assessment is paramount for effective therapeutic decisions.
Purpose:
- To describe recent advances in medical treatment for severe and fulminating UC.
- To provide guidance on general management, fluid/electrolyte balance, and nutritional support.
- To introduce novel therapeutic approaches and discuss the controversial role of surgical intervention.
Summary:
- Effective management requires precise severity assessment, general supportive care (fluids, electrolytes, nutrition), and timely surgical consideration for intractable cases.
- Two novel treatments are highlighted: continuous intravenous cyclosporine and leucocytapheresis using the Cellsoba filter.
- The optimal timing for surgical intervention in severe UC remains an area of ongoing clinical debate.
Impact:
- Highlights critical factors for improving outcomes in severe ulcerative colitis patients.
- Introduces potentially life-saving advanced therapies for refractory cases.
- Informs clinical decision-making regarding the integration of new treatments and surgical strategies.